| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/1996 | WO1996023063A1 Method of producing and purifying enzymes |
| 08/01/1996 | WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness |
| 08/01/1996 | WO1996023000A1 Ligands for eph-like receptors |
| 08/01/1996 | WO1996022999A1 Peptides which inhibit viruses |
| 08/01/1996 | WO1996022997A1 Compounds with growth hormone releasing properties |
| 08/01/1996 | WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | WO1996022788A1 LYMPHOTOXIN-α/β COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS |
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996022783A1 Method of enhancing nutrient uptake |
| 08/01/1996 | WO1996022782A1 Novel highly potent agonists of growth hormone releasing hormone |
| 08/01/1996 | WO1996022773A1 Methods and compositions for lipidization of hydrophilic molecules |
| 08/01/1996 | WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 08/01/1996 | WO1996022693A1 Self-renewing pluripotent hematopoietic stem cell compositions, methods of use, and culture systems therefor |
| 08/01/1996 | WO1996022688A1 A proliferation-inhibiting gene sequence and its use in the treatment of cancer and other diseases |
| 08/01/1996 | WO1996016170A3 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 08/01/1996 | WO1996015231A3 Method for producing biologicals in protein-free culture |
| 08/01/1996 | WO1996013593A3 Soluble single chain t cell receptors |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 08/01/1996 | WO1996013586A3 Histiocyte-secreted factor (hsf) |
| 08/01/1996 | WO1996012811A3 Yeast telomerase components and methods using them |
| 08/01/1996 | WO1996012736A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY |
| 08/01/1996 | WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 08/01/1996 | DE4442587A1 Transfection of eukaryotic cells |
| 08/01/1996 | DE19502436A1 New complementary peptide(s) for treating prion protein disease |
| 08/01/1996 | CA2211842A1 Method of enhancing nutrient uptake |
| 08/01/1996 | CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | CA2211468A1 Recombinant dna comprising dna coding for myosin heavy chain sm1 isoform protein inserted into vector dna, microorganism carrying the recombinant dna, and an agent for treatment of arteriosclerosis comprising the recombinant dna |
| 08/01/1996 | CA2211443A1 Lymphotoxin-.alpha./.beta. complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 08/01/1996 | CA2211442A1 Methods and compositions for lipidization of hydrophilic molecules |
| 08/01/1996 | CA2211176A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 08/01/1996 | CA2211142A1 Human retinoid x receptor - gamma (hrxr-gamma) |
| 08/01/1996 | CA2211122A1 Novel highly potent agonists of growth hormone releasing hormone |
| 08/01/1996 | CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | CA2210644A1 Ligands for eph-like receptors |
| 08/01/1996 | CA2210419A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 07/31/1996 | EP0724016A1 Toxoplasma gondii mimotope polypeptides and uses thereof |
| 07/31/1996 | EP0723974A1 Derivatives of mercaptoalkanoyldipeptides, their preparation and pharmaceutical compositions containing them |
| 07/31/1996 | EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 07/31/1996 | EP0723594A1 A plasmid vector useful for the expression of a foreign dna sequence |
| 07/31/1996 | EP0723593A1 USE OF $g(a)-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE |
| 07/31/1996 | EP0723589A1 Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease |
| 07/31/1996 | EP0723588A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family |
| 07/31/1996 | EP0723587A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 07/31/1996 | EP0723585A1 Customized proteases |
| 07/31/1996 | EP0723584A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/31/1996 | EP0723555A1 Chimeric proteins which block complement activation |
| 07/31/1996 | EP0723552A1 Oligopeptides derived from c-reactive protein fragments |
| 07/31/1996 | EP0723551A1 Hapten-marked peptides |
| 07/31/1996 | EP0723536A1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 07/31/1996 | EP0723460A1 Gene therapy of the nervous system |
| 07/31/1996 | EP0723458A1 Immune modulation with class ii alpha-chain fragments |
| 07/31/1996 | EP0723456A1 Methods for stimulating erythropoiesis using thrombopoietin |
| 07/31/1996 | EP0723455A1 Methods of inhibiting phagocytosis |
| 07/31/1996 | EP0723453A1 Method of treating reproductive disorders |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/31/1996 | EP0511393B1 Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism |
| 07/31/1996 | EP0491849B1 A method for the purification of transforming growth factor (tgf-) |
| 07/31/1996 | EP0471754B1 Production of vascular endothelial cell growth factor and dna encoding same |
| 07/31/1996 | EP0469074B1 Cysteine added variants il-3 and chemical modifications thereof |
| 07/31/1996 | EP0469060B1 Autoantibodies which enhance the rate of a chemical reaction |
| 07/31/1996 | EP0446313B1 Fusion proteins comprising TraTp and at least one LHRH analogue |
| 07/31/1996 | EP0422175B1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
| 07/31/1996 | EP0394326B1 Methods for the production of conformationally stabilized cell adhesion peptides |
| 07/31/1996 | CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 07/31/1996 | CN1128046A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 07/31/1996 | CN1128043A Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 07/31/1996 | CN1127785A Human thrombopoietin |
| 07/31/1996 | CN1032427C Tigerish bird-catching spider toxin and preparing method thereof |
| 07/31/1996 | CN1032425C Production of proteins in active forms |
| 07/31/1996 | CN1032401C Regeneration and transformation of cotton |
| 07/31/1996 | CA2168381A1 Toxoplasma gondii mimotypic polypeptides and use thereof |
| 07/30/1996 | US5541312 Production of interferon |
| 07/30/1996 | US5541311 Nucleic acid encoding synthesis-deficient thermostable DNA polymerase |
| 07/30/1996 | US5541309 Modified apoaequorin having increased bioluminescent activity |
| 07/30/1996 | US5541298 Method of determining metastatic potential of tumor cells |
| 07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
| 07/30/1996 | US5541295 Monoclonal antibodies |
| 07/30/1996 | US5541293 Consensus human leukocyte interferon |
| 07/30/1996 | US5541292 Malaria vaccine |
| 07/30/1996 | US5541291 Polypeptides |
| 07/30/1996 | US5541288 Peptide having elastase inhibitory activity and producing method thereof |
| 07/30/1996 | US5541161 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin |
| 07/30/1996 | US5541159 Calcitonin derivatives |
| 07/30/1996 | US5541156 Protein |
| 07/30/1996 | US5541112 Genes which influence pichia proteolytic activity, and uses therefor |
| 07/30/1996 | US5541110 Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| 07/30/1996 | US5541109 Dna and dna sequences for cells |
| 07/30/1996 | US5541106 Cell matrix stimulated attachment and hemidesmosome assembly |
| 07/30/1996 | US5541104 Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 |
| 07/30/1996 | US5541101 Anti-oxytocin receptor antibodies |
| 07/30/1996 | US5541100 Hiv, influenza |
| 07/30/1996 | US5541088 Recombinant process of producing non-glycosylated B-cell defferentiation factor |
| 07/30/1996 | US5541087 Expression and export technology of proteins as immunofusins |
| 07/30/1996 | US5541086 Method for the production of porcine growth hormone using a synthetic gene in yeast cells |
| 07/30/1996 | US5541085 Method for preparing orphan receptor ligands |
| 07/30/1996 | US5541084 Hybrid yeast promoter comprising an ENO2 UAS and TATA region and an additional UAS located between said ENO2 UAS and TATA region |
| 07/30/1996 | US5541078 Antigenic peptide sequence of echinococcus granulosus and diagnostic applications |